Bank of New York Mellon Corp - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 73 filers reported holding GRITSTONE ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2023$469,186
-17.0%
272,783
-5.9%
0.00%
Q2 2023$565,375
+314.8%
289,936
+491.3%
0.00%
Q1 2023$136,312
-19.4%
49,0330.0%0.00%
Q4 2022$169,164
+34.3%
49,033
-0.3%
0.00%
Q3 2022$126,000
+1.6%
49,165
-3.9%
0.00%
Q2 2022$124,000
-81.2%
51,185
-68.0%
0.00%
Q1 2022$658,000
-67.5%
159,854
+1.6%
0.00%
Q4 2021$2,023,000
+17.5%
157,348
-1.3%
0.00%
Q3 2021$1,722,000
+41.7%
159,374
+19.7%
0.00%
Q2 2021$1,215,000
+14.1%
133,112
+17.8%
0.00%
Q1 2021$1,065,000
+205.2%
112,970
+27.4%
0.00%
Q4 2020$349,000
+43.6%
88,648
-3.6%
0.00%
Q3 2020$243,000
-60.2%
91,969
+0.1%
0.00%
Q2 2020$611,000
+27.8%
91,897
+12.0%
0.00%
Q1 2020$478,000
-35.0%
82,082
+0.2%
0.00%
Q4 2019$735,000
+8.1%
81,902
+3.9%
0.00%
Q3 2019$680,000
-23.6%
78,791
-1.3%
0.00%
Q2 2019$890,000
+204.8%
79,862
+264.0%
0.00%
Q1 2019$292,00021,9380.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,102,929$18,059,047,0004.95%
Svennilson Peter 3,102,934$18,059,0002.29%
Casdin Capital, LLC 2,270,000$13,211,0001.40%
FRAZIER MANAGEMENT LLC 2,061,758$11,999,0001.36%
Redmile Group, LLC 3,068,194$17,857,0000.50%
Alphabet Inc. 929,022$5,407,0000.36%
Bleichroeder LP 169,039$984,0000.26%
Leap Investments LP 14,400$84,0000.12%
DAFNA Capital Management LLC 50,000$291,0000.12%
Blackstone Inc. 2,567,445$14,943,0000.11%
View complete list of GRITSTONE ONCOLOGY INC shareholders